{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:06:54Z","timestamp":1790809614064,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Esophageal self-expanding metal stents (SEMS) effectively restore oral intake in malignant obstruction, yet stent dysfunction remains a frequent clinical challenge. We aimed to identify and compare predictors of stent dysfunction in fully versus partially covered self-expanding metal stents (fcSEMS vs. pcSEMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective cohort included patients undergoing SEMS placement for malignant esophageal strictures between 2014 and 2023. Stent dysfunction comprised migration, tumor overgrowth, or food bolus impaction. Patients with benign or anastomotic strictures, prior ablative therapy, or uncovered SEMS were excluded. Cumulative incidence and Fine-Gray subdistribution hazard models were used, treating death as a competing event. Interaction terms assessed effect modification by stent type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 249 screened patients, 188 were included (mean age 68.0\u2009\u00b1\u200910.7 years; 78.7% male; 92 pcSEMS and 96 fcSEMS); technical success was 97.3%. Dysfunction occurred in 29.8% and was more frequent with fcSEMS than pcSEMS (36.5% vs. 22.8%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), primarily due to migration (31.3% vs. 10.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Within 12 months, 37 patients (19.7%) died before dysfunction and were treated as competing events. In adjusted Fine-Gray models, strictures caused by other malignancies (non-squamous\/non-adenocarcinoma) were strongly associated with dysfunction in the fcSEMS group (sHR 6.53; 95% CI 2.51\u201316.98;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), with significant effect modification by stent type (sHR interaction 14.1; 95% CI 2.08\u201395.8;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Larger stricture diameter independently predicted dysfunction with fcSEMS (sHR per mm 1.21; 95% CI 1.01\u20131.45;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), while lower esophageal location showed a borderline association (sHR 2.33; 95% CI 0.89\u20136.07;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08). Adverse-event rates were comparable (35.9% vs. 43.8%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.27).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patterns of stent dysfunction differed between fcSEMS and pcSEMS. Tumor etiology and stricture anatomy may guide risk-stratified stent selection and help reduce reinterventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-05414-z","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:45:38Z","timestamp":1790761538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of dysfunction in fully versus partially covered self-expanding metal stents for malignant esophageal strictures: a 10-year multicenter study"],"prefix":"10.1186","volume":"26","author":[{"given":"\u00d6zlem","family":"\u00c7elebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"J\u00fcrgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Levenfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kouladouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Maibier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Blasberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Hochberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Trung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Razpotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"5","key":"5414_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2036.2007.03589.x","volume":"27","author":"H Bergquist","year":"2008","unstructured":"Bergquist H, Johnsson A, Hammerlid E, Wenger U, Lundell L, Ruth M. Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther. 2008;27(5):385\u201395.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5414_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00595-019-01878-7","volume":"50","author":"M Watanabe","year":"2020","unstructured":"Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50(1):12\u201320.","journal-title":"Surg Today"},{"issue":"3","key":"5414_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022;163(3):649\u2013e582.","journal-title":"Gastroenterology"},{"issue":"11","key":"5414_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust T, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493\u2013505.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5414_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10620-018-4957-z","volume":"63","author":"A Lai","year":"2018","unstructured":"Lai A, Lipka S, Kumar A, Sethi S, Bromberg D, Li N, et al. Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis. Dig Dis Sci. 2018;63(4):1025\u201334.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"5414_CR6","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1007\/s00464-025-12032-5","volume":"39","author":"WJ Kim","year":"2025","unstructured":"Kim WJ, Choi CW, Kim SJ, Ryu DG, Park SB, Jang JO, et al. Predictors of clinical failure after stenting for malignant esophageal stricture: a single-institution retrospective analysis. Surg Endosc. 2025;39(10):6626\u201335.","journal-title":"Surg Endosc"},{"issue":"10","key":"5414_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1055\/s-2004-825855","volume":"36","author":"MY Homs","year":"2004","unstructured":"Homs MY, Steyerberg EW, Kuipers EJ, van der Gaast A, Haringsma J, van Blankenstein M, et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy. 2004;36(10):880\u20136.","journal-title":"Endoscopy"},{"issue":"1","key":"5414_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1055\/a-0644-2495","volume":"51","author":"AN Reijm","year":"2019","unstructured":"Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW. Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time. Endoscopy. 2019;51(1):18\u201329.","journal-title":"Endoscopy"},{"issue":"10","key":"5414_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1055\/a-0620-8135","volume":"50","author":"P Didden","year":"2018","unstructured":"Didden P, Reijm AN, Erler NS, Wolters LMM, Tang TJ, Ter Borg PCJ, et al. Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study). Endoscopy. 2018;50(10):961\u201371.","journal-title":"Endoscopy"},{"issue":"12","key":"5414_CR10","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.cgh.2020.09.010","volume":"19","author":"KK Das","year":"2021","unstructured":"Das KK, Hasak S, Elhanafi S, Visrodia KH, Ginsberg GG, Ahmad NA, et al. Performance and Predictors of Migration of Partially and Fully Covered Esophageal Self-Expanding Metal Stents for Malignant Dysphagia. Clin Gastroenterol Hepatol. 2021;19(12):2656\u2013e632.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"5414_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.gie.2010.01.070","volume":"72","author":"NC Van Heel","year":"2010","unstructured":"Van Heel NC, Haringsma J, Spaander MC, Didden P, Bruno MJ, Kuipers EJ. Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc. 2010;72(2):249\u201354.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"5414_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.gie.2009.10.027","volume":"71","author":"PB Cotton","year":"2010","unstructured":"Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446\u201354.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"5414_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00004836-199203000-00004","volume":"14","author":"M Dakkak","year":"1992","unstructured":"Dakkak M, Bennett JR. A new dysphagia score with objective validation. J Clin Gastroenterol. 1992;14(2):99\u2013100.","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"5414_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/gut.23.12.1060","volume":"23","author":"AL Ogilvie","year":"1982","unstructured":"Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23(12):1060\u20137.","journal-title":"Gut"},{"issue":"446","key":"5414_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"5414_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals Stat. 1988;16(3):1141\u201354.","journal-title":"Annals Stat"},{"key":"5414_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000."},{"issue":"6","key":"5414_CR18","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00464-012-2738-x","volume":"27","author":"G Seven","year":"2013","unstructured":"Seven G, Irani S, Ross AS, Gan SI, Gluck M, Low D, et al. Partially versus fully covered self-expanding metal stents for benign and malignant esophageal conditions: a single center experience. Surg Endosc. 2013;27(6):2185\u201392.","journal-title":"Surg Endosc"},{"issue":"6","key":"5414_CR19","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/nu15061524","volume":"15","author":"W Dudzic","year":"2023","unstructured":"Dudzic W, P\u0142atkowski C, Folwarski M, Meyer-Szary J, Ka\u017amierczak-Siedlecka K, Ekman M, et al. Nutritional Status and the Outcomes of Endoscopic Stenting in Benign and Malignant Diseases of Esophagus. Nutrients. 2023;15(6):1524.","journal-title":"Nutrients"},{"issue":"6","key":"5414_CR20","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1055\/a-0890-3284","volume":"7","author":"S Thomas","year":"2019","unstructured":"Thomas S, Siddiqui AA, Taylor LJ, Parbhu S, Cao C, Loren D, et al. Fully-covered esophageal stent migration rates in benign and malignant disease: a multicenter retrospective study. Endosc Int Open. 2019;7(6):E751\u20136.","journal-title":"Endosc Int Open"},{"issue":"5","key":"5414_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jfma.2024.05.014","volume":"124","author":"IT Chou","year":"2025","unstructured":"Chou IT, Yu FJ, Shih HY, Liu YW, Lee JY, Chou SH, et al. Risk factors of stent migration in esophageal cancer patients who underwent fully-covered self-expanding metal stents for malignant dysphagia or tracheoesophageal fistula. J Formos Med Assoc. 2025;124(5):432\u20138.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"5414_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10620-017-4839-9","volume":"63","author":"H So","year":"2018","unstructured":"So H, Ahn JY, Han S, Jung K, Na HK, Lee JH, et al. Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal Obstruction. Dig Dis Sci. 2018;63(1):234\u201341.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"5414_CR23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/j.1572-0241.2001.03923.x","volume":"96","author":"N Vakil","year":"2001","unstructured":"Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001;96(6):1791\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"5414_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.radonc.2007.07.008","volume":"84","author":"KL Zhao","year":"2007","unstructured":"Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, et al. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol. 2007;84(3):283\u20139.","journal-title":"Radiother Oncol"},{"issue":"3","key":"5414_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4240\/wjgs.v6.i3.38","volume":"6","author":"TE Pavlidis","year":"2014","unstructured":"Pavlidis TE, Pavlidis ET. Role of stenting in the palliation of gastroesophageal junction cancer: A brief review. World J Gastrointest Surg. 2014;6(3):38\u201341.","journal-title":"World J Gastrointest Surg"},{"key":"5414_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.compbiomed.2018.06.031","volume":"100","author":"H Mozafari","year":"2018","unstructured":"Mozafari H, Dong P, Zhao S, Bi Y, Han X, Gu L. Migration resistance of esophageal stents: The role of stent design. Comput Biol Med. 2018;100:43\u20139.","journal-title":"Comput Biol Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05414-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:52:57Z","timestamp":1790808777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05414-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5414"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05414-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"17 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Charit\u00e9 - Universit\u00e4tsmedizin Berlin (Number: EA1\/120\/25). The requirement for informed consent was waived by the Ethics Committee of Charit\u00e9 - Universit\u00e4tsmedizin Berlin due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"593"}}